SINGAPORE - Two companies have merged to create Asia's first tech-based firm to offer healthcare solutions tailored to Asian women.
This focus on Asian women is important because some global standard tests for women's health have generated less precise results due to genetic differences amongst various phenotypes, the company said on Tuesday . The deal, which will create an entity valued at US$72 million, is backed by institutional investors, including multinational Genting, government agency Enterprise Singapore and investment company SNS Holdings.
The company is also developing a point of care kit called OvaCis that can distinguish benign from malignant ovarian cysts in five minutes. It is also looking into a blood-based test for the early detection of ovarian cancer and a technology that is one of the first epigenetics-based early detection tests for breast cancer in Asian women.The company plans to commercialise these technologies across Asia by 2020.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Asia stocks rise as stimulus, policy hopes calm nervous investorsAsian stocks rose on Monday as hopes of more stimulus from central banks around the world and steps being taken by major economies such as Germany ...
Прочитайте больше »
Stocks to watch: HMI, Figtree Holdings, Hong Leong Asia, RE&S Holdings, PS GroupTHE following companies saw new developments that may affect trading of their shares on Tuesday: Read more at The Business Times.
Прочитайте больше »